YM
Yusuke Miyazaki
Principal at ANRI
Tokyo, Tokyo
Overview
Yusuke Miyazaki is a Principal at ANRI in Tokyo, with a background in investing in seed and pre-seed stages across sectors like Pharmaceuticals, Consumer Health, and BioTech. Notable highlights of his career include serving as a Senior Principal at ANRI and making strategic investments in companies like Typewriter Therapeutics, Inc. and Universal Brain Inc.
Work Experience
Senior Principal
2018 - Current
Venture capital, investment, seed/early stage start-ups
Seed Investor
2023
Seed Investor
2023
Seed Investor
2022
Seed Investor
2020
Investor
2020
Investor
2020
Seed Investor
2019
Strand Therapeutics is a biopharmaceutical company applying synthetic biology to RNA therapeutics to develop single dose mRNA treatments.
Raised $104,200,000.00 from Potentum partners, Playground Global, Eli Lilly & Company Foundation, FPV Ventures, Redmile Group, BeiGene, ANRI and Camford Capital.
Seed Investor
2019
Seed Investor
2019